“Rising Adoption of Prefilled Syringes in Biologic Drug Delivery”
- Prefilled syringes are gaining prominence as the preferred packaging format for biologic and biosimilar drugs due to their sterility and ease of administration
- The increasing popularity of self-administration and home care is driving demand for patient-friendly, ready-to-use delivery systems
- These syringes help minimize dosing errors, improve treatment compliance, and reduce the risk of contamination
- Pharmaceutical companies are investing in innovative prefilled technologies such as autoinjectors and dual-chamber systems
- For instance, Sanofi’s insulin drug Lantus is widely available in prefilled syringe formats, supporting at-home diabetic care and simplifying administration
